- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05453071
The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic Sclerosis
The Effects of Cognitive Exercise Therapy Approach on Vascularization, Muscle Strength, Functionality, Anti-Inflammatory and Biopsycosocial Status in Individuals With Systemic Sclerosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Systemic sclerosis is an inflammatory and chronic autoimmune disease. Systemic sclerosis, which was first defined by Hippocrates as thickened skin, can also progress with skin involvement and fibrosis of internal organs. Although the exact pathogenesis of the disease is not understood, it is thought to occur as a result of interactions between factors affecting collagen synthesis, fibrosis, capillary (vasculopathy) changes and immunological mechanisms. The role of inflammation has an important place in the pathogenesis of the disease. One of the most important factors governing the inflammatory process is cytokines. Changes in the response of the cytokines mentioned in systemic sclerosis, respiratory system involvement and related decrease in walking capacity, loss of muscle strength, weakening of hand functions, as well as weakening the psychological and social aspects of a person who is a biopsychosocial being. In addition to local physiotherapy applications such as paraffin applications, exercises for the face and hands, active stretching, exercise approaches such as exercises for aerobic endurance are also beneficial. However, there is no mention of a standardized exercise model, the quality of life of individuals with systemic sclerosis, which is a rare disease, activities of daily living, studies in which the social and psychological aspects of the individual are included in the treatment, and named and defined exercise methods are lacking in the literature. It is seen that studies are generally carried out with scales and functional tests.
Cognitive Exercise Therapy Approach, presents an example of an innovative biopsychosocial model with its own biopsychosocial scale, the basic exercise model of which is core stabilization exercises, including pain management, mood management and sexual information management. For individuals with systemic sclerosis, which is in the group of rare diseases, it is necessary to present the results of the intervention with objective evaluation methods to the literature. In this study, it is aimed to present an exercise model named for this disease group with objective results by examining the effects of Cognitive Exercise Therapy Approach (BETY) on vascularization, muscle strength, functionality, anti-inflammatory and biopsychosocial status in individuals with systemic sclerosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 34349
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having been diagnosed with Systemic Sclerosis
- Being between the ages of 18-65
- Regular attendance at the rheumatology outpatient clinic at Hacettepe University
- No medication change in the last 3 months
Exclusion Criteria:
- Having a severe musculoskeletal disability Being diagnosed with pulmonary hypertension
- FVC value below 50%
- History of active infection
- Symptomatic cardiac involvement
- Having a psychiatric disorder
- Pregnancy
- History of active myositis
- Renal failure
- Not being literate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: BETY Group
Since 2004, group exercise sessions have been organized as a routine form of treatment for individuals diagnosed with rheumatism in the Department of Physiotherapy and Rehabilitation of Hacettepe University.
The first evaluation will be made if the individuals who come to the routine doctor's examination agree to participate in the study.
According to being included in one of the two groups as those who decided to attend the BETY sessions that have been going on for 18 years and those who did not agree to attend the sessions; The individuals included in the BETY group (Group 1) will be evaluated on the day of the last exercise session after their participation in the 12-week exercise group.
|
BETY, based on function-oriented core stabilization exercises, will be applied in patients with systemic sclerosis.
This exercise model includes pain management strategies, dance therapy-authentic movement.
Function-oriented core stabilization exercises have the feature of being made difficult against gravity according to the person's ability to do.
Initial exercises start from the stage where the distal segment of the extremity is on the ground, called closed-kinetic.
This level, which is quite easy, becomes more difficult following the success of the individual.
It can be started from the mat level and progressed by modifying it with theraband and exercise ball.
It is used at the beginning and end of dance therapy and authentic movement sessions.
In the session, cognitive restructuring technique is used to break the vicious cycle of pain-emotional-spasm during exercise.
This exercise model is the main rehabilitation approach of the Rheumatological Rehabilitation Unit.
|
|
No Intervention: Control Group
Individuals (Group 2), who do not agree to participate in BETY sessions but agree to participate in evaluations with 12-week intervals, will be evaluated when they come for their routine check-ups at 12-week intervals, and recommendations given routinely.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BETY-Biopsychosocial Questionnaire (BETY-BQ)
Time Frame: 3 Months
|
It is a 5-point Likert-type scale consisting of 30 questions developed with individuals with rheumatism.
It is a practical scale that evaluates individuals in terms of fatigue and functionality, sleep, mood, sexuality, pain and sociability.
Each question is scored as "0= never, 1=yes rarely, 2=yes sometimes, 3=yes often 4=yes always" and gives a total score over 30 items.
A high score means a low biopsychosocial level.
The total score is scored between 0-120
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Rodnan Skin Score (mRSS)
Time Frame: 3 Months
|
A method in which the skin firmness of the person is evaluated by holding the skin between two fingers and looking at the degree of stretching.
It is a standard disease activity scoring applied in doctor's examinations for Systemic Sclerosis patients.
It evaluates the skin hardness of 17 different parts of the body.
0= normal skin , 1= mild skin thickness, 2= moderate skin thickness, 3= severe skin thickness.
A high score indicates increased skin thickness.
The total score is scored between 0-51
|
3 Months
|
|
Quality of Life Scale Short Form-36 (SF-36)
Time Frame: 3 Months
|
SF-36 Quality of Life Scale; It is a 36-item, 11-question scale that allows general health screening with 8 sub-parameters consisting of general health, physical function, social function, pain, emotional well-being, role limitations due to physical health, role limitations due to emotional problems and vitality.
It is a generic scale, Items are scored as '0 = worst health condition 100 = best health state'.
Each subcategory is scored between 0 and 100 points, with a high score indicating good health.
|
3 Months
|
|
Scleroderma Health Assessment Questionnaire (SHAQ)
Time Frame: 3 Months
|
Dressing and grooming, arising, eating, walking, hygiene, reach, grip and activities are evaluated with 20 items divided into eight areas.
The answers given to each question range from "without any difficulty (0)", "with some difficulty (1)", "with much difficulty (2)" and "unable to do (3)".
Afterwards, it is requested to show how Raynaud's phenomenon, digital ulcers, intestinal involvement, respiratory and overall disease severity affect the daily activity level on a 15 cm long section.
The SHAQ-global score is formed by dividing the sum of the scores of these 8 parameters and 5 items by 13.
High score indicates low functionality.
|
3 Months
|
|
Duruoz Hand Index
Time Frame: 3 Months
|
Questionnaire form-18 is a likert-type scale that evaluates different hand functions.
It can score between 0-90.
A high score means a low hand functions.
|
3 Months
|
|
Six-minute walk test (6MWT)
Time Frame: 3 Months
|
In order to evaluate the aerobic capacity of individuals, they will be toured for 6 minutes at a distance of 30 meters.
The average 6MWT is between 400 and 700 meters.
|
3 Months
|
|
Evaluation of vascular structure
Time Frame: 3 Months
|
Doppler ultrasonography technique is an ultrasonography method that evaluates the blood flow passing through the lumens of the vascular structures in the body.
In this method, flow velocity and resistance measurements can be made in vascular structures by measuring the changing return frequencies of sound waves sent from ultrasound probes to the tissues due to the movement of blood cells flowing in the vessel.
In the study, the vascular status of the arteries on the forearm and palmar face will be examined by Doppler ultrasonography.
|
3 Months
|
|
Evaluation of anti-inflammatory effects
Time Frame: 3 Months
|
Examination of the cytokine profiles of the patients will be done before and after the treatment for Group 1, and for Group 2 at the initial and final evaluation.
IL-6, IL-10, TNF-a and Irisin values, which are the cytokines that the literature focuses on in the pathophysiology of systemic sclerosis, will be checked by blood analysis with the same measurement units at Hacettepe University Central Laboratory.
|
3 Months
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3 Months
|
It is a scale that evaluates anxiety and depression, which are psychological symptoms that can occur with diseases, with 14 items. Each question is scored between 0-3 points and a total score between 0 and 21 points can be obtained. A total score of 0-7 is considered normal, a score of 8-10 is considered borderline abnormal (borderline case), and a score of 11-21 is considered abnormal (case). 0-7 points are normal, 8-10 points are borderline abnormal (borderline case) and 11-21 points are abnormal (case) It is considered. |
3 Months
|
|
Modified Hand Mobility in Scleroderma (mHAMIS)
Time Frame: 3 Months
|
It is a method in which the hand functions of individuals are evaluated by a physiotherapist.
It evaluates 4 different hand functions based on observation.
|
3 Months
|
|
Evaluation of muscle strength
Time Frame: 3 Months
|
Muscle strength assessment of knee joint flexor and extensor muscle group will be made with Biodex System Pro3® (Biodex Corp, Shirley, NY, USA) device.
Before each measurement, patients will be tested 3 times, and knee flexor and extensor maximal concentric isokinetic muscle strength will be measured at 180°/sec 10 repetitions and 60°/sec 5 repetitions angular speeds, with a 30 sec rest interval after each angular velocity.
|
3 Months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Go 19/191
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Sclerosis
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Japan, Romania, United States, Mexico, Argentina, Israel, Greece, Chile, Serbia, South Korea, Italy, Poland, Portugal, United Kingdom
-
Beijing GoBroad HospitalCARsgen Therapeutics Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE) | Systemic Sclerosis (SSc)China
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Serbia
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
argenxRecruitingSystemic Sclerosis (SSc)Croatia, Spain, Denmark, Italy, Germany, Lithuania, United Kingdom, Netherlands, Poland, Belgium, United States, Switzerland, Mexico, Argentina, France, Bulgaria, Chile, Greece, Serbia, Portugal, Puerto Rico, Czechia, Romania, Hungary
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
University of PatrasRecruitingSSc-Systemic SclerosisGreece
-
Union Hospital, Tongji Medical College, Huazhong...CARsgen Therapeutics Co., Ltd.RecruitingSSc-Systemic SclerosisChina
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
Clinical Trials on Cognitive Exercise Therapy Approach (BETY)
-
Kahramanmaras Sutcu Imam UniversityCompletedPrimer Sjogren's SyndromeTurkey (Türkiye)
-
Eastern Mediterranean UniversityHacettepe UniversityCompletedRheumatic DiseasesTurkey (Türkiye)
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Kahramanmaras Sutcu Imam UniversityHacettepe UniversityCompleted
-
Erkin Oğuz SARINot yet recruitingPost-Traumatic Stress DisorderTurkey
-
Hasan Kalyoncu UniversityCompleted
-
Hacettepe UniversityRecruitingScleroderma, Localized | Scleroderma | Systemic Sclerosis (SSc) | Scleroderma Systemic | Scleroderma (Limited and Diffuse) | Juvenile Systemic Sclerosis | Systemic Sclerosis - 2013 ACR/EULAR Classification CriteriaTurkey (Türkiye)
-
Hasan Kalyoncu UniversityCompletedHeadache | Temporomandibular DisordersTurkey (Türkiye)
-
Acibadem UniversityBezmialem Vakif UniversityRecruitingPrimary Dysmenorrhea | DysmenorrheaTurkey (Türkiye)
-
Bezmialem Vakif UniversityCompletedAutism Spectrum Disorder | Executive Function | Patient ParticipationTurkey